OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38 | -78.7% | 12,242 | -63.8% | 0.00% | -100.0% |
| Q1 2023 | $178 | -99.7% | 33,849 | +121.5% | 0.00% | +100.0% |
| Q3 2022 | $63,000 | +53.7% | 15,285 | +51.4% | 0.00% | – |
| Q2 2022 | $41,000 | -68.0% | 10,094 | -45.2% | 0.00% | -100.0% |
| Q4 2021 | $128,000 | -67.3% | 18,415 | -52.9% | 0.00% | -50.0% |
| Q3 2021 | $391,000 | +58.3% | 39,101 | +159.4% | 0.00% | +100.0% |
| Q1 2021 | $247,000 | +10.8% | 15,072 | +39.8% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | -5.5% | 10,778 | -62.0% | 0.00% | -50.0% |
| Q2 2020 | $236,000 | +206.5% | 28,347 | +82.1% | 0.00% | +100.0% |
| Q1 2020 | $77,000 | +140.6% | 15,568 | +47.5% | 0.00% | – |
| Q3 2019 | $32,000 | -93.0% | 10,553 | -78.5% | 0.00% | -100.0% |
| Q1 2017 | $455,000 | +337.5% | 49,024 | +1884.0% | 0.00% | +300.0% |
| Q1 2015 | $104,000 | – | 2,471 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |